Literature DB >> 27221826

Survival in Head and Neck Cancers - Results of A Multi- Institution Study.

Ambakumar Nandakumar1, Ambakumar Nandakumar1.   

Abstract

BACKGROUND: The prime output of Hospital Based Cancer Registries is stage and treatment based survival to evaluate patient care, but because of challenges of obtaining follow-up details a separate study on Patterns of Care and Survival for selected sites was initiated under the National Cancer Registry Programme of India. The results of stage and treatment based survival for head and neck cancers by individual organ sites are presented.
MATERIALS AND METHODS: A standardized Patient Information Form recorded the details and entered on-line at www.hbccrindia.org to a central repository - National Centre for Disease Informatics and Research. Cases from 12 institutions diagnosed between 1 January 2006 and 31 December 2008 comprised the study subjects. The patterns of treatment were examined for 14053 and survival for 4773 patients from five institutions who reported at least 70% follow-up as of 31 December 2012.
RESULTS: Surgical treatment with radiation for cancer tongue and mouth showed five year cumulative survival (FCS) of 67.5% and 60.4% respectively for locally advanced stage. Chemo-radiation compared to radiation alone showed better survival benefit of around 15% in both oro and hypo-pharyngeal cancers and their FCS was 40.0%; Hazard Ratio (HR):1.5;CI=1.2-1.9) and 38.7%; (HR):1.7; CI=1.3-2.2).
CONCLUSIONS: The awareness about the requirement of concurrent chemo-radiation in specifically cancers of the oro and hypopharynx has to be promoted in developing countries. The annual (2014) estimate number of new Head and Neck cancers with locally advanced disease in India is around 140,000 and 91,000 (65%) patients do not receive the benefit of optimal treatment with ensuing poorer survival.

Entities:  

Mesh:

Year:  2016        PMID: 27221826     DOI: 10.7314/apjcp.2016.17.4.1745

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.

Authors:  Madhup Rastogi; Rohini Khurana; Swaroop Revannasiddaiah; Isha Jaiswal; Sambit S Nanda; Pooja Gupta; Kundan S Chufal; M L Bhatt
Journal:  Support Care Cancer       Date:  2016-12-16       Impact factor: 3.603

2.  A Survival Analysis of Hypopharyngeal Cancer Patients: A Hospital-Cancer registry Based Study.

Authors:  Manigreeva Krishnatreya; Amal Chandra Kataki; Jagannath Dev Sharma; Nizara Baishya; Tashnin Rahman; Mouchumee Bhattcharyya; Ashok Kumar Das; Manoj Kalita
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-12-27

3.  Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study.

Authors:  Yujiao Deng; Meng Wang; Linghui Zhou; Yi Zheng; Na Li; Tian Tian; Zhen Zhai; Si Yang; Qian Hao; Ying Wu; Dingli Song; Dai Zhang; Jun Lyu; Zhijun Dai
Journal:  Aging (Albany NY)       Date:  2020-02-08       Impact factor: 5.682

4.  Microbial and molecular differences according to the location of head and neck cancers.

Authors:  Yun Kyeong Kim; Eun Jung Kwon; Yeuni Yu; Jayoung Kim; Soo-Yeon Woo; Hee-Sun Choi; Munju Kwon; Keehoon Jung; Hyung-Sik Kim; Hae Ryoun Park; Dongjun Lee; Yun Hak Kim
Journal:  Cancer Cell Int       Date:  2022-03-26       Impact factor: 5.722

5.  Cancer Statistics, 2020: Report From National Cancer Registry Programme, India.

Authors:  Prashant Mathur; Krishnan Sathishkumar; Meesha Chaturvedi; Priyanka Das; Kondalli Lakshminarayana Sudarshan; Stephen Santhappan; Vinodh Nallasamy; Anish John; Sandeep Narasimhan; Francis Selvaraj Roselind
Journal:  JCO Glob Oncol       Date:  2020-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.